Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study.
J Clin Oncol
; 35(7): 751-758, 2017 Mar.
Article
en En
| MEDLINE
| ID: mdl-27870562
Texto completo:
1
Colección:
01-internacional
Asunto principal:
Neoplasias de la Mama
/
ADN de Neoplasias
/
Biomarcadores de Tumor
/
Metilación de ADN
Tipo de estudio:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Middle aged
Idioma:
En
Revista:
J Clin Oncol
Año:
2017
Tipo del documento:
Article